The US Food and Drug Administration has finally approved GlaxoSmithKline's Q-Pan H5N1 vaccine for treating H5N1 avian flu. The vaccine had received a unanimous nod from the FDA's vaccine advisory board but the agency revealed it will not be approving the vaccine at that time after GSK reported a technical hitch. The FDA revealed that the vaccine is the first to make use of an adjuvant and added that it will not be available for commercial use but will be ...
Read MoreYou have just read an article categorized health
titled GSK's Q-Pan H5N1 Vaccine Receives FDA Nod.
Written by:
editor - Monday, December 2, 2013
There are currently no comments for "GSK's Q-Pan H5N1 Vaccine Receives FDA Nod"
Post a Comment